Medicare CHOICE Act of 2018
USA115th CongressHR-5686| House
| Updated: 6/12/2018
Erik Paulsen
Republican Representative
Minnesota
Cosponsors (6)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018 This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 575.
Committee on Ways and Means discharged.
Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I.
Health
Alternative treatmentsDrug trafficking and controlled substancesHealth care costs and insuranceMedicarePrescription drugs
Medicare CHOICE Act of 2018
USA115th CongressHR-5686| House
| Updated: 6/12/2018
Medicare Clear Health Options in Care for Enrollees Act of 2018 or the Medicare CHOICE Act of 2018 This bill requires Medicare and Medicare Advantage prescription drug plan (PDP) sponsors to annually disclose information to enrollees about: (1) the adverse effects of prolonged opioid use; and (2) the plan's coverage of nonpharmacological therapies, devices, and non-opioid medications. PDP sponsors may limit disclosure to a subset of enrollees (such as those who were prescribed an opioid in the previous two-year period).
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Referred to the Subcommittee on Health.
Placed on the Union Calendar, Calendar No. 575.
Committee on Ways and Means discharged.
Reported by the Committee on Energy and Commerce. H. Rept. 115-741, Part I.
Erik Paulsen
Republican Representative
Minnesota
Cosponsors (6)
Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Alternative treatmentsDrug trafficking and controlled substancesHealth care costs and insuranceMedicarePrescription drugs